Using MRI, we measured disease activity and brain atrophy in nine multiple sclerosis patients treated with autologous hematopoietic stem cell transplantation (AHSCT) for a mean follow up of 63 months. We show that AHSCT is associated to a longlasting suppression of inflammation and to a marked decrease of the rate of brain atrophy after the second year following treatment.
The long-term effect of AHSCT on MRI measures of MS evolution: A five-year follow-up study
MARROSU, MARIA GIOVANNA;LA NASA, GIORGIO;COCCO, ELEONORA;
2007-01-01
Abstract
Using MRI, we measured disease activity and brain atrophy in nine multiple sclerosis patients treated with autologous hematopoietic stem cell transplantation (AHSCT) for a mean follow up of 63 months. We show that AHSCT is associated to a longlasting suppression of inflammation and to a marked decrease of the rate of brain atrophy after the second year following treatment.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Roccatogliata-L._2007_Mult.-Scler.pdf
Solo gestori archivio
Tipologia:
versione editoriale
Dimensione
158.06 kB
Formato
Adobe PDF
|
158.06 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
